The effect of antifungal agents on the in vitro susceptibility of Candida albicans to apo-lactoferrin

Arch Oral Biol. 1994 Oct;39(10):921-3. doi: 10.1016/0003-9969(94)90026-4.

Abstract

The effect of subminimal inhibitory concentrations (MICs) of nystatin, amphotericin B, clotrimazole, miconazole and 5-fluorocytosine on the in vitro susceptibility of Candida albicans to physiological concentrations of apo-lactoferrin was investigated. Pre-exposure of C. albicans in 1:4 and 1:16 MICs of the antifungals resulted in an increased resistance to apo-lactoferrin-mediated cell death. Preincubation of Candida in tunicamycin (an agent that inhibits the synthesis of yeast cell-wall mannoproteins) and subsequent exposure to apo-lactoferrin enhanced the antifungal activity, whilst addition of ergosterol (a yeast cell-wall component) to the assay suspension had no significant effect. These results taken together indicate that apo-lactoferrin, an important component of saliva, interacts with cell-membrane constituents of C. albicans such as mannoproteins, and may modulate the effect of topical antifungal agents commonly prescribed for oral candidoses.

MeSH terms

  • Amphotericin B / pharmacology
  • Antifungal Agents / pharmacology*
  • Apoproteins / pharmacology*
  • Candida albicans / drug effects*
  • Cell Death / drug effects
  • Cell Wall / chemistry
  • Clotrimazole / pharmacology
  • Drug Resistance, Microbial
  • Ergosterol / pharmacology
  • Flucytosine / pharmacology
  • Lactoferrin / pharmacology*
  • Membrane Glycoproteins / antagonists & inhibitors
  • Miconazole / pharmacology
  • Nystatin / pharmacology
  • Tunicamycin / pharmacology

Substances

  • Antifungal Agents
  • Apoproteins
  • Membrane Glycoproteins
  • apolactoferrin
  • mannoproteins
  • Tunicamycin
  • Nystatin
  • Miconazole
  • Amphotericin B
  • Flucytosine
  • Lactoferrin
  • Clotrimazole
  • Ergosterol